Advertisement
Journal Home
Search for

Volume 196, Issue 1, Pages 64-69 (20 March 2010)


View previous. 16 of 27 View next.

Solid-phase microextraction for the detection of codeine, morphine and 6-monoacetylmorphine in human hair by gas chromatography–mass spectrometry

M. Mollerab, K. Aleksaa, P. Walaseka, T. Karaskova, G. KorenabCorresponding Author Informationemail address

Received 9 June 2009; accepted 21 July 2009. published online 18 January 2010.

Abstract 

Introduction

Opiate hair analysis continues to prove difficult due to the scarcity of hair sample and low drug concentrations. For this reason, we developed a sensitive method utilizing headspace solid-phase microextraction (HS-SPME) coupled with gas chromatography–mass spectrometry (GC–MS) for the detection of three principle opiates; codeine, morphine, and 6-acetylmorphine.

Methods

Experimental conditions for HS-SPME and GC–MS were systematically optimized to produce the sensitive analytical method reported. Briefly, opiates were extracted from adult hair with methanol under agitation. The methanolic extract was then decanted into SPME autosampler vials, where deuterated standards of each of the 3 opiates were added at a concentration of 2ng/mg. Samples were dried under N2, derivatized, and subjected to HS-SPME coupled with GC/MS for analysis.

Results

Preliminary datum for this study indicates detection limits for these 3 opiates are superior to that reported in the literature; an LOQ of 0.01ng/mg for morphine and 6-acetylmorphine and 0.005ng/mg for codeine. Linearity was evident between 0.01ng/mg and 5ng/mg for each opiate, with R2 above 0.992. The robustness of the method was demonstrated to be acceptable as inter-day and intra-day precision fell below 15% for each opiate analyzed.

Conclusion

Compared with conventional methods, this method of detection for opiates is fast, simple, and accurate, with the sensitivity and specificity required in forensic and clinical toxicology.

a Motherisk Program, Division of Clinical Pharmacology & Toxicology, Hospital for Sick Children, , Toronto, Ontario Canada, M5G1X8

b Department of Pharmacology & Toxicology, University of Toronto, Toronto, Ontario, Canada

Corresponding Author InformationCorresponding author at: Division of Clinical Pharmacology & Toxicology, Hospital for Sick Children, 555 University Avenue, Toronto, Ontario, Canada, M5G1X8. Tel.: +1 416 813 5781; fax: +1 416 813 7562.

PII: S0379-0738(09)00547-7

doi:10.1016/j.forsciint.2009.12.046


View previous. 16 of 27 View next.

Advertisement